Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Clinicopathologic characteristics of YES-associated protein 1 overexpression and its relationship to tumor biomarkers in gastric cancer.

Zhang J, Yang YC, Zhu JS, Zhou Z, Chen WX.

Int J Immunopathol Pharmacol. 2012 Oct-Dec;25(4):977-87.

PMID:
23298488
2.

YES-associated protein 1 promotes adenocarcinoma growth and metastasis through activation of the receptor tyrosine kinase Axl.

Cui ZL, Han FF, Peng XH, Chen X, Luan CY, Han RC, Xu WG, Guo XJ.

Int J Immunopathol Pharmacol. 2012 Oct-Dec;25(4):989-1001.

PMID:
23298489
3.

Overexpression of YAP1 is correlated with progression, metastasis and poor prognosis in patients with gastric carcinoma.

Hu X, Xin Y, Xiao Y, Zhao J.

Pathol Oncol Res. 2014 Oct;20(4):805-11. doi: 10.1007/s12253-014-9757-y. Epub 2014 Mar 19.

PMID:
24643316
4.

Distinct prognostic values of YAP1 in gastric cancer.

Yu L, Gao C, Feng B, Wang L, Tian X, Wang H, Ma D.

Tumour Biol. 2017 Apr;39(4):1010428317695926. doi: 10.1177/1010428317695926.

PMID:
28381174
5.

Effects of the hippo signaling pathway in human gastric cancer.

Zhou GX, Li XY, Zhang Q, Zhao K, Zhang CP, Xue CH, Yang K, Tian ZB.

Asian Pac J Cancer Prev. 2013;14(9):5199-205.

6.

Nuclear expression of Yes-associated protein 1 correlates with poor prognosis in intestinal type gastric cancer.

Song M, Cheong JH, Kim H, Noh SH, Kim H.

Anticancer Res. 2012 Sep;32(9):3827-34.

PMID:
22993325
7.

Low angiomotin-p130 with concomitant high Yes-associated protein 1 expression is associated with adverse prognosis of advanced gastric cancer.

Hong SA, Son MW, Cho J, Jang SH, Lee HJ, Lee JH, Cho HD, Oh MH, Lee MS.

APMIS. 2017 Nov;125(11):996-1006. doi: 10.1111/apm.12750. Epub 2017 Sep 8.

PMID:
28885730
8.

The significance of NTR1 expression and its correlation with Ī²-catenin and EGFR in gastric cancer.

Zhou Z, Xie J, Cai Y, Yang S, Chen Y, Wu H.

Diagn Pathol. 2015 Jul 28;10:128. doi: 10.1186/s13000-015-0356-3. Erratum in: Diagn Pathol. 2015;10:173. Zhou, Zhouyi [corrected to Zhou, Zhiyi].

9.
10.

Clinical significance of immunogenic cell death biomarker rage and early growth response 1 in human primary gastric adenocarcinoma.

Xu XC, Gao H, Zhang WB, Abuduhadeer X, Wang YH.

Int J Immunopathol Pharmacol. 2013 Apr-Jun;26(2):485-93.

PMID:
23755764
11.

MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinical-pathological features and outcome.

Galuppini F, Bertazza L, Barollo S, Cavedon E, Rugge M, Guzzardo V, Sacchi D, Watutantrige-Fernando S, Vianello F, Mian C, Pennelli G.

Virchows Arch. 2017 Nov;471(5):651-658. doi: 10.1007/s00428-017-2227-7. Epub 2017 Aug 31.

PMID:
28861609
12.

Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis.

Kang W, Tong JH, Chan AW, Lee TL, Lung RW, Leung PP, So KK, Wu K, Fan D, Yu J, Sung JJ, To KF.

Clin Cancer Res. 2011 Apr 15;17(8):2130-9. doi: 10.1158/1078-0432.CCR-10-2467. Epub 2011 Feb 23.

13.
14.

Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.

Chen H, Shen DP, Zhang ZZ, Liu JH, Shen YY, Ni XZ.

World J Gastroenterol. 2015 Feb 14;21(6):1838-44. doi: 10.3748/wjg.v21.i6.1838.

15.

Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells.

Diep CH, Zucker KM, Hostetter G, Watanabe A, Hu C, Munoz RM, Von Hoff DD, Han H.

PLoS One. 2012;7(3):e32783. doi: 10.1371/journal.pone.0032783. Epub 2012 Mar 1.

16.
17.

Expression of Yes-associated proteinĀ 1 and its clinical significance in ovarian serous cystadenocarcinoma.

Cho SY, Kim K, Park MS, Jang MY, Choi YH, Han S, Shin HM, Chung C, Han HY, Yang JB, Ko YB, Yoo HJ.

Oncol Rep. 2017 May;37(5):2620-2632. doi: 10.3892/or.2017.5517. Epub 2017 Mar 21.

18.

Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma.

Li P, Sun D, Li X, He Y, Li W, Zhao J, Wang Y, Wang H, Xin Y.

J Cancer Res Clin Oncol. 2016 Aug;142(8):1765-73. doi: 10.1007/s00432-016-2188-2. Epub 2016 Jun 20.

19.

The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer.

Song S, Honjo S, Jin J, Chang SS, Scott AW, Chen Q, Kalhor N, Correa AM, Hofstetter WL, Albarracin CT, Wu TT, Johnson RL, Hung MC, Ajani JA.

Clin Cancer Res. 2015 Jun 1;21(11):2580-90. doi: 10.1158/1078-0432.CCR-14-2191. Epub 2015 Mar 4.

20.

Expression and significance of homeodomain protein Cdx2 in gastric carcinoma and precancerous lesions.

Qin R, Wang NN, Chu J, Wang X.

World J Gastroenterol. 2012 Jul 7;18(25):3296-302. doi: 10.3748/wjg.v18.i25.3296.

Supplemental Content

Support Center